-

The Law Offices of Frank R. Cruz Announces Investigation of NextCure, Inc. (NXTC) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of NextCure, Inc. (“NextCure” or the “Company”) (NASDAQ: NXTC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On January 13, 2020, NextCure disclosed that Eli Lilly and Company had ended its collaboration agreement for the research and development of the Company’s leading product candidate, NC318, a first-in-class immunomedicine targeting the Siglec-15 immunomodulatory receptor particularly for patients with advanced or metastatic solid tumors.

On this news, the Company’s share price fell $4.70, or 8%, to close at $52.00 per share on January 13, 2020, thereby injuring investors.

Then, on July 13, 2020, before the market opened, NextCure announced that it was no longer planning to “advance the non-small cell lung cancer (NSCLC) and ovarian cancer cohorts in the stage 2 portion of the Simon 2-stage trial.” The same day, the Company announced that its Chief Medical Officer resigned.

On this news, the Company’s share price fell $9.73, or 54%, to close at $8.15 per share on July 13, 2020, thereby injuring investors further.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased NextCure securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

Industry:

The Law Offices of Frank R. Cruz

NASDAQ:NXTC
Release Versions
English
$Cashtags
$NXTC
Hashtags
#classaction
#fraud
#investors

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

More News From The Law Offices of Frank R. Cruz

Securities Fraud Lawsuit Filed Against UP Fintech Holding Limited: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against UP Fintech Holding Limited ("UP Fintech" or the "Company") (NASDAQ: TIGR) on behalf of investors who purchased or otherwise acquired UP Fintech Holding Limited securities from April 22, 2024 to June 2, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Liao v. Up Fintech Holdings Limited et al, filed on October 26, 2026 in the U.S. District Court District of New Jersey (Case No. 2:26-cv...

Deadline Alert: D-Wave Quantum, Inc. Shareholders Have Until December 15, 2026 to Seek Lead Plaintiff Appointment in Securities Fraud Lawsuit, The Law Offices of Frank R. Cruz Notes

LOS ANGELES--(BUSINESS WIRE)--The deadline for D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) investors to seek appointment as lead plaintiff in a securities class action lawsuit is December 15, 2026. The lawsuit was filed on behalf of investors who purchased or otherwise acquired D-Wave Quantum, Inc. securities from February 26, 2026 to August 25, 2026, inclusive. The Law Offices of Frank R. Cruz today reminded investors of the deadline in the case, Fessler v. D-Wave Quantum, I...

Securities Fraud Lawsuit Filed Against D-Wave Quantum, Inc.: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) on behalf of investors who purchased or otherwise acquired D-Wave Quantum, Inc. securities from February 26, 2026 to August 25, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Fessler v. D-Wave Quantum, Inc. et al., filed on October 15, 2026 in the U.S. District Court California Northern District (Case No. 3:26-cv-11953...
Back to Newsroom